EU approves Illumina's plan to divest cancer test maker Grail

Illumina

12/04/2024 10:45

BRUSSELS, April 12 (Reuters) - The EU's executive
Commission approved Illumina's  ILMN.O  plan to unwind its
completed acquisition of cancer diagnostic test maker Grail
 GRAL.O , it said in a statement on Friday. 
    The U.S. gene sequencing company Illumina had announced late
last year to divest Grail, after the companies battled both U.S.
and European antitrust enforcers for more than two years and
faced fierce opposition from activist investor Carl Icahn.

 (Writing by Nette Nöstlinger, Editing by Charlotte Van
Campenhout)
 ((Annette.Noestlinger@thomsonreuters.com;))